Eliscription Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.43 Cr
- Satisfied Charges ₹ 5.31 Cr
- Revenue Growth 2.44%
- Profit Growth -9.18%
- Ebitda -35.61%
- Net Worth -81.11%
- Total Assets 27.27%
About Eliscription
Eliscription Private Limited (EPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 March 2013 and has a history of 11 years and ten months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.43 Cr. The company has closed loans amounting to ₹5.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Eliscription Private Limited India is Sri Kasala as CEO. Ramesh Datla, Vanitha Datla, and Sri Kasala serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900TG2013PTC086622
- Company No.
086622
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Eliscription?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sri Kasala | CEO | 01-Jan-2021 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vanitha Datla  | Director | 26-Mar-2013 | Current |
| Ramesh Datla | Director | 26-Mar-2013 | Current |
| Sri Kasala | Whole-Time Director | 01-Jan-2018 | Current |
Financial Performance of Eliscription.
Eliscription Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.44% increase. The company also saw a slight decrease in profitability, with a 9.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 81.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eliscription?
In 2023, Eliscription had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elico Healthcare Services LimitedRamesh Datla and Vanitha Datla are mutual person
Srinivasa Farms Private LimitedVanitha Datla is a mutual person
Visaka Industries Ltd.Vanitha Datla is a mutual person
Cyient Dlm LimitedVanitha Datla is a mutual person
Elico Mechoptronix Private LimitedRamesh Datla and Vanitha Datla are mutual person
- Elico Ltd
Ramesh Datla and Vanitha Datla are mutual person
Charges (Loans)
₹64.30 M
₹53.09 M
Charges Breakdown by Lending Institutions
- Others : 6.43 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2022 | Others | ₹1.43 Cr | Open |
| 31 Mar 2021 | Others | ₹2.50 Cr | Open |
| 24 Jun 2020 | Others | ₹2.50 Cr | Open |
| 30 Sep 2021 | Axis Bank Limited | ₹5.59 M | Satisfied |
| 15 Feb 2019 | Axis Bank Limited | ₹6.40 M | Satisfied |
How Many Employees Work at Eliscription?
Eliscription has a workforce of 1 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eliscription, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eliscription's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.